Stability of Turoctocog Alfa, a Recombinant Factor VIII Product, during Continuous Infusion In Vitro

Objective  Turoctocog alfa is a recombinant factor VIII (rFVIII) for the prevention and treatment of bleeding in patients with hemophilia A, including those undergoing surgery and invasive medical procedures. This in vitro study evaluated the physical and chemical stability of turoctocog alfa during...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeyama, Masahiro, Nøhr, Anne Mette, Pollard, Debra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655264/
https://www.ncbi.nlm.nih.gov/pubmed/33195971
http://dx.doi.org/10.1055/s-0040-1719082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655264/
https://www.ncbi.nlm.nih.gov/pubmed/33195971
http://dx.doi.org/10.1055/s-0040-1719082

Ejemplares similares